Severe weather alerts warning of a "significant threat to life" appeared on phones across the UK due to a testing error, the ...

Dr. Reddy's launches immuno-oncology drug Toripalimab in India for nasopharyngeal carcinoma, expanding access to innovative treatment.

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

Court of Appeal judge says there is no dispute that police officer’s torts had been ‘oppressive, arbitrary or ...

Nam Cheong has secured multi-year offshore support vessel (OSV) charter contracts worth RM1.22 billion ($368.7 million). The ...

Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic ...

The parade in New York City, presented by department store chain Macy’s, was first held in 1924 under the heading “Macy’s ...

Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...

Capital A Bhd posted a net profit of RM1.64bil for the third quarter ended Sept 30, 2024 (3Q24), swinging into the black from ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...